Skip To Main Content
Lilly
Menu closed
Lilly
  • Account Login/ Register
  • Medical Home
  • Lilly Temperature Exposure Assessment Tool
  • Independent Research
Ask Lilly

We're here to help.

Question Contact Us
Expand contact lilly
Globe Loading... Reveal available languages
Lilly

You are now leaving the LillyMedical.ca website

The website you are visiting may be intended for audiences in a different geography. Please note that such website and its content (including privacy and security policies) have been construed in accordance with local laws and regulations, which may differ from the ones applicable to LillyMedical.ca.
If the link you clicked on takes you to a site maintained by a third party, the third party is solely responsible for its content. Eli Lilly Canada Inc. does not control, influence, or endorse the site, and the opinions, claims, or comments expressed on the site should not be attributed to Eli Lilly Canada Inc. Eli Lilly Canada Inc. is not responsible for the privacy policy of any third party Web sites.
Please review the privacy and security policies of every Web site you visit.​
Click "Continue" to proceed or "Return" to return to LillyMedical.ca

Additional Healthcare Professional Resources:

Lilly Temperature Exposure Assessment Tool

Lilly Temperature Exposure Assessment Tool externallink

Access Lilly’s Temperature Exposure Assessment tool to evaluate past temperature exposures for Lilly Marketed Products.

Medical Information

To search for medical information, please select a product below.



B

Basaglar®

(insulin glargine [rDNA origin] injection)

C

Cyramza®

(ramucirumab intravenous injection)

Cialis®

(tadalafil tablets)

E

Evista®

(raloxifene hydrochloride tablets)

Emgality®

(galcanezumab injection)

Ebglyss™

(lebrikizumab injection)

F

Forteo®

(teriparatide [rDNA origin] injection)

H

Humatrope®

(somatropin for injection)

Humulin® Therapies

Humalog® Therapies

M

Mounjaro®

(tirzepatide injection)

O

Omvoh™

(mirikizumab injection)

Olumiant®

(baricitinib tablets)

R

Retevmo™

(selpercatinib capsules)

T

Trulicity®

(dulaglutide injection)

Taltz®

(ixekizumab for injection)

V

Verzenio®

(abemaciclib tablets)

Contact Us to learn more about Lilly's medical information.

  • Disclaimer
  • Terms of Use
  • Privacy Statement
  • Copyright
  • Accessibility
     

    This website is intended for Canadian Health Care Professionals only.

    VV-Canada Medical-US-DEL-0244 03/2025 | © Eli Lilly Canada Inc. 2025. All rights reserved.

    Product names listed above are trademarks or registered trademarks owned by or licensed to Eli Lilly and Company, its subsidiaries, or affiliates.

    Lilly